INR 330.05
(-3.96%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 2 Billion INR | 9.28% |
2022 | 1.83 Billion INR | 58.75% |
2021 | 1.15 Billion INR | 22.42% |
2020 | 944.04 Million INR | -22.91% |
2019 | 1.22 Billion INR | 29.88% |
2018 | 942.84 Million INR | 0.09% |
2017 | 942.01 Million INR | 49.49% |
2016 | 630.16 Million INR | 25.37% |
2015 | 502.63 Million INR | 36.58% |
2014 | 368.01 Million INR | 40.92% |
2013 | 261.15 Million INR | 30.6% |
2012 | 199.95 Million INR | 18.25% |
2011 | 169.09 Million INR | 32.45% |
2010 | 127.66 Million INR | 23.29% |
2009 | 103.55 Million INR | -3.28% |
2008 | 107.06 Million INR | -7.08% |
2007 | 115.22 Million INR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2023 FY | 2 Billion INR | 9.28% |
2023 Q2 | 1.92 Billion INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2023 Q4 | 2 Billion INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2022 FY | 1.83 Billion INR | 58.75% |
2022 Q3 | - INR | -100.0% |
2022 Q2 | 1.68 Billion INR | 0.0% |
2022 Q4 | 1.83 Billion INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2021 Q4 | 1.15 Billion INR | 0.0% |
2021 FY | 1.15 Billion INR | 22.42% |
2021 Q1 | - INR | -100.0% |
2021 Q2 | 1.15 Billion INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2020 Q2 | 1.05 Billion INR | 0.0% |
2020 FY | 944.04 Million INR | -22.91% |
2020 Q4 | 944.04 Million INR | 0.0% |
2019 Q4 | 1.22 Billion INR | 0.0% |
2019 Q2 | 930.29 Million INR | 0.0% |
2019 FY | 1.22 Billion INR | 29.88% |
2018 Q4 | 942.84 Million INR | 0.0% |
2018 Q2 | 963.11 Million INR | 0.0% |
2018 FY | 942.84 Million INR | 0.09% |
2017 Q4 | 942.01 Million INR | 0.0% |
2017 FY | 942.01 Million INR | 49.49% |
2017 Q2 | 822.56 Million INR | 0.0% |
2016 Q4 | 630.16 Million INR | 0.0% |
2016 FY | 630.16 Million INR | 25.37% |
2016 Q2 | 582.36 Million INR | 0.0% |
2015 Q2 | 490.16 Million INR | 0.0% |
2015 Q4 | 502.63 Million INR | 0.0% |
2015 FY | 502.63 Million INR | 36.58% |
2014 Q2 | 336.78 Million INR | 0.0% |
2014 FY | 368.01 Million INR | 40.92% |
2014 Q4 | 368.01 Million INR | 0.0% |
2013 Q4 | 261.15 Million INR | 0.0% |
2013 FY | 261.15 Million INR | 30.6% |
2013 Q2 | 197.45 Million INR | 0.0% |
2012 Q4 | 199.95 Million INR | 0.0% |
2012 FY | 199.95 Million INR | 18.25% |
2011 Q4 | 169.09 Million INR | 0.0% |
2011 FY | 169.09 Million INR | 32.45% |
2010 FY | 127.66 Million INR | 23.29% |
2009 FY | 103.55 Million INR | -3.28% |
2008 FY | 107.06 Million INR | -7.08% |
2007 FY | 115.22 Million INR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Bal Pharma Limited | 878.11 Million INR | -128.31% |
Achyut Healthcare Limited | 568 Thousand INR | -352861.444% |
Alkem Laboratories Limited | 26.61 Billion INR | 92.466% |
Divi's Laboratories Limited | 31.84 Billion INR | 93.703% |
Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 92.022% |
Glenmark Life Sciences Limited | 6.66 Billion INR | 69.924% |
Krebs Biochemicals & Industries Limited | 97.96 Million INR | -1946.487% |
Mankind Pharma Limited | 15.53 Billion INR | 87.094% |
Medicamen Biotech Limited | 593.75 Million INR | -237.653% |
Medico Remedies Limited | 163.37 Million INR | -1127.151% |
Megasoft Limited | - INR | -Infinity% |
Procter & Gamble Health Limited | 1.09 Billion INR | -83.743% |
Piramal Pharma Limited | 21.75 Billion INR | 90.786% |
Sequent Scientific Limited | 3.46 Billion INR | 42.096% |
Sigachi Industries Limited | 707.2 Million INR | -183.484% |
Ajanta Pharma Limited | 8.28 Billion INR | 75.798% |
Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 97.968% |
Brooks Laboratories Limited | 96.1 Million INR | -1986.008% |
Aarti Pharmalabs Limited | 6.42 Billion INR | 68.814% |
Themis Medicare Limited | 705.74 Million INR | -184.072% |
Unichem Laboratories Limited | 7.04 Billion INR | 71.55% |
Hester Biosciences Limited | 755.81 Million INR | -165.255% |
Venus Remedies Limited | 1.21 Billion INR | -64.748% |
Indoco Remedies Limited | 3.53 Billion INR | 43.216% |
Ind-Swift Limited | 640.91 Million INR | -212.806% |
Aarti Drugs Limited | 4.85 Billion INR | 58.739% |
Alpa Laboratories Limited | 136.65 Million INR | -1367.089% |
AstraZeneca Pharma India Limited | 2.27 Billion INR | 12.024% |
Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 96.845% |
Granules India Limited | 13 Billion INR | 84.585% |
Hikal Limited | 3.03 Billion INR | 33.991% |
RPG Life Sciences Limited | 1.01 Billion INR | -98.497% |
Suven Pharmaceuticals Limited | 2.31 Billion INR | 13.285% |
Windlas Biotech Limited | 621.89 Million INR | -222.376% |
ZIM Laboratories Limited | 812.62 Million INR | -146.708% |
Ind-Swift Laboratories Limited | 104.57 Million INR | -1817.076% |
IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 52.81% |
Jubilant Pharmova Limited | 12.89 Billion INR | 84.454% |
Aurobindo Pharma Limited | 98.08 Billion INR | 97.956% |
Bajaj HealthCare Limited | 1.44 Billion INR | -39.187% |
Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -7762.968% |
Ipca Laboratories Limited | 24.71 Billion INR | 91.888% |
Lasa Supergenerics Limited | 190.43 Million INR | -952.764% |
Laurus Labs Limited | 18.45 Billion INR | 89.136% |
NATCO Pharma Limited | 7 Billion INR | 71.38% |
Nectar Lifesciences Limited | 7.09 Billion INR | 71.729% |
Shilpa Medicare Limited | 3.44 Billion INR | 41.877% |
Solara Active Pharma Sciences Limited | 3.59 Billion INR | 44.264% |
Torrent Pharmaceuticals Limited | 22.79 Billion INR | 91.203% |
Wanbury Limited | 360.23 Million INR | -456.536% |
Wockhardt Limited | 6.4 Billion INR | 68.675% |
Strides Pharma Science Limited | 11.26 Billion INR | 82.199% |
Bliss GVS Pharma Limited | 1.18 Billion INR | -69.258% |
Suven Life Sciences Limited | 7.08 Million INR | -28196.697% |
Amrutanjan Health Care Limited | 289.04 Million INR | -593.597% |
Alembic Pharmaceuticals Limited | 16.43 Billion INR | 87.802% |
Eris Lifesciences Limited | 1.89 Billion INR | -6.057% |
Lupin Limited | 49.53 Billion INR | 95.953% |
Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
Syncom Formulations (India) Limited | 210.81 Million INR | -850.986% |
Valiant Laboratories Limited | 100.15 Million INR | -1901.738% |
Zydus Lifesciences Limited | 34.41 Billion INR | 94.175% |
FDC Limited | 3.88 Billion INR | 48.447% |
J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 60.104% |
Novartis India Limited | 448.6 Million INR | -346.906% |
Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -1236.815% |
Neuland Laboratories Limited | 3.5 Billion INR | 42.788% |
Morepen Laboratories Limited | 2.48 Billion INR | 19.354% |
Kilitch Drugs (India) Limited | 39.88 Million INR | -4927.134% |
Mangalam Drugs & Organics Limited | 1.23 Billion INR | -62.15% |